Literature DB >> 1818219

Ultrastructural study of asexual development of Cryptosporidium parvum in a human intestinal cell line.

T Aji1, T Flanigan, R Marshall, C Kaetzel, M Aikawa.   

Abstract

The lack of a well-defined in vitro model of Cryptosporidium infection has severely hampered research on the biology of parasitic invasion of the host cell and on intracellular development of the parasite. In vitro infection of the differentiated human enterocyte cell line HT29.74 was studied by electron microscopy to detect changes in parasite and host cell morphology. Cryptosporidium oocysts obtained from AIDS patients were applied to a monolayer of cloned differentiated HT29.74 cells. Parasites and infected cells were evaluated by transmission electron microscopy at 20 min, 1 h, 6 h, 24 h and 7 days. Sporozoite invagination within the epithelial cell microvilli and subsequent penetration was evident at 1 h. At 6 h, the development of a dense band and feeder layer was visible. Development of the trophozoite into a schizont occurred over 24 h. Micronemes and dense granules were clearly visible within sporozoites and merozoites. Organization of vacuoles within the cytoplasm of the host cell was evident below the dense band. A sexual Cryptosporidium development in vitro was morphologically no different from initial development in vivo. In vitro infection of HT29.74 cells provides an excellent model to study parasite-host cell interaction and asexual parasite development.

Entities:  

Mesh:

Year:  1991        PMID: 1818219

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  7 in total

1.  Cholangiocyte myosin IIB is required for localized aggregation of sodium glucose cotransporter 1 to sites of Cryptosporidium parvum cellular invasion and facilitates parasite internalization.

Authors:  Steven P O'Hara; Gabriella B Gajdos; Christy E Trussoni; Patrick L Splinter; Nicholas F LaRusso
Journal:  Infect Immun       Date:  2010-05-10       Impact factor: 3.441

2.  In vitro inhibition of Cryptosporidium parvum infection by human monoclonal antibodies.

Authors:  B C Elliot; A V Wisnewski; J Johnson; D Fenwick-Smith; P Wiest; D Hamer; T Kresina; T P Flanigan
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

3.  Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro.

Authors:  D H Hamer; H Ward; S Tzipori; M E Pereira; J P Alroy; G T Keusch
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

4.  Microtubule inhibitors block Cryptosporidium parvum infection of a human enterocyte cell line.

Authors:  P M Wiest; J H Johnson; T P Flanigan
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

5.  Cdc42 and the actin-related protein/neural Wiskott-Aldrich syndrome protein network mediate cellular invasion by Cryptosporidium parvum.

Authors:  Xian-Ming Chen; Bing Q Huang; Patrick L Splinter; James D Orth; Daniel D Billadeau; Mark A McNiven; Nicholas F LaRusso
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

6.  Over-expression and localization of a host protein on the membrane of Cryptosporidium parvum infected epithelial cells.

Authors:  Yi-Lin Yang; Myrna G Serrano; Abhineet S Sheoran; Patricio A Manque; Gregory A Buck; Giovanni Widmer
Journal:  Mol Biochem Parasitol       Date:  2009-07-22       Impact factor: 1.759

7.  Cryptosporidium parvum Cpn60 targets a relict organelle.

Authors:  Christina E Riordan; Jeffrey G Ault; Susan G Langreth; Janet S Keithly
Journal:  Curr Genet       Date:  2003-08-20       Impact factor: 3.886

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.